ProCE Banner Activity

CE

Pneumococcal Disease Prevention: Integrating the Latest Vaccine Updates Into Practice

Video

On-demand webcast of expert faculty presentation and case discussion on updates in pneumococcal disease and prevention, including strategies to improve vaccine uptake among pediatric patients and older adults.

Pharmacy Technicians: 1.50 contact hours (0.15 CEUs)

Pharmacists: 1.50 contact hours (0.15 CEUs)

Released: December 20, 2024

Expiration: December 19, 2025

Share

Faculty

Mary Barna Bridgeman

Mary Barna Bridgeman, PharmD, BCPS, BCGP

Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
International Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Richard H. Dang

Richard H. Dang, PharmD, APh, FCPhA

Assistant Professor of Clinical Pharmacy
Assistant Director of the Residency Programs
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Los Angeles, California

Jeff Goad

Jeff Goad, PharmD, MPH, FAPhA, FASHP, FISTM

Professor of Pharmacy Practice
Chapman University School of Pharmacy
Irvine, California

Provided by

Provided by ProCE, LLC

ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA

Target Audience

This activity is intended for community and clinical pharmacists, pharmacy technicians, and other healthcare professionals involved in recommending or providing pneumococcal vaccine services for pediatric and/or adult populations.

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with vaccination.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Summarize prominent pneumococcal serotypes causing disease and severity in pediatric and adult populations

  • Update pediatric and adult pneumococcal vaccine strategies based on the latest developments, scientific data, and recommendations

  • Provide strong pneumococcal vaccine recommendations for adult candidates that promote acceptance in candidate populations with suboptimal uptake rates

Disclosure

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Mary Barna Bridgeman, PharmD, BCPS, BCGP

Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
International Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Mary Barna Bridgeman, PharmD, BCPS, BCGP, has no relevant financial relationships to disclose.

Richard H. Dang, PharmD, APh, FCPhA

Assistant Professor of Clinical Pharmacy
Assistant Director of the Residency Programs
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Los Angeles, California

Richard H. Dang, PharmD, APh, FCPhA, has no relevant financial relationships to disclose.

Jeff Goad, PharmD, MPH, FAPhA, FASHP, FISTM

Professor of Pharmacy Practice
Chapman University School of Pharmacy
Irvine, California

Jeff Goad, PharmD, MPH, FAPhA, FASHP, FISTM: consultant/advisor/speaker: Merck, Moderna, Valneva.

The planners and content peer reviewers from ProCE, LLC do not have any relevant financial relationships to disclose.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Pharmacists and Pharmacy Technicians 

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-24-009-H06-P/T has been assigned to this home study application-based activity. This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This activity is provided at no cost to participants. Completion of the evaluation and the post-test with a score of 65% or higher are required to receive CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.